Familial trend in polycystic ovarian syndrome: Report of two cases

Annals of African Medicine

Volumn 12, Issue 3, 2013, Pages 182-184

  Joe Kechebelu, N ^a,c   Mbamara, S ^b   Ikechebelu, J ^c  

^a ANAMBRA STATE UNIVERSITY   (Nigeria)

^b NNAMDI AZIKIWE UNIVERSITY   (Nigeria)

^c Life Specialist Hospital Limited   (Nigeria)

Author keywords

Familial trend; genetics; polycystic ovarian syndrome

Indexed keywords

CLOMIFENE CITRATE; FOLLITROPIN; GESTAGEN; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; METFORMIN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; PROLACTIN;

ADULT; AMENORRHEA AND OLIGOMENORRHEA; ANOVULATION; ARTICLE; BODY MASS; BREAST TUMOR; CASE REPORT; COMORBIDITY; DIABETES MELLITUS; DIPLOPIA; DRUG DOSE INCREASE; DYSMENORRHEA; ECHOGRAPHY; ENDOMETRIAL THICKNESS; ENDOMETRIUM; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; GALACTORRHEA; HORMONE DETERMINATION; HUMAN; HYPERTENSION; INFERTILITY; MENARCHE; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; MULTIPLE CYCLE TREATMENT; NECK TUMOR; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PHYSICAL EXAMINATION; THYROID DISEASE; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; TREATMENT RESPONSE; VAGINAL DELIVERY; WEIGHT CHANGE; WITHDRAWAL BLEEDING;

ADULT; ANOVULATION; CLOMIPHENE; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INFERTILITY, FEMALE; LAPAROSCOPY; OLIGOMENORRHEA; POLYCYSTIC OVARY SYNDROME; TREATMENT OUTCOME;

EID: 84884584329     PISSN: 15963519     EISSN: 09755764     Source Type: Journal    
DOI: 10.4103/1596-3519.117630     Document Type: Article

References (11)

1. Khan KA, Stas S, Kurukulasuriya LR. Polycystic Ovarian Syndrome. J Cardiometab Syndr 2006;1:125-30.
2. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352:1223-36.
3. Xita N, Georgion I, Tsatsoulis A. The genetic basis of polycystic ovary sndrome. Eur J Endocrinol 2002;147:717-25. (Pubitemid 36032959)
4. Amato P, Simpson JL. The genetics of polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004;18:707-18. (Pubitemid 40424606)
5. Unluturk U, Harmani A, Kocaefe C, Yildiz BO. The genetic basis of the polycystic ovary syndrome: A literature review including discusion of PPAR - Gamma. PPAR Res 2007;2007:49109.
6. Kasher-Miller M, Azziz R. Heritability and the risk of developing androgen excess. J Steroid Biochem Mol Biol 1999;69:261-8.
7. Mao W, Li M, Chen Y, Lu C, Wang Y, Zhang X, et al. Study on the mode of inheritance for familial polycystic ovary syndrome. Zhonghua Yi Xue Yi Chau Xue Za Zhi 2001;18:21-3. (Pubitemid 32172236)
8. Moini A, Eslami B. Familial associations between polycystic ovarian syndrome and common diseases. J Assist Reprod Genet 2009;26:123-7.
9. Cheang KI, Nestler JE, Futterweit W. Risk of Cardiovascular events in the mothers of women with poly cystic ovary syndrome. Endocr Pract 2008;14:1084-94.
10. Gumus II, Koktener A, Dogan D, Turhan NO. Polycystic ovary syndrome and fibrocystic breast disease: Is there any association. Arch Gynaecol Obstet 2009;280:249-53.
11. D'Amelio R, Farris M, Grande S, Feraudo E, Iuliano A, Zichella L. Association between polycystic ovary and fibrocystic breast disease. Gynecol Obstet Invest 2001;51:134-7.